Neuralieve, Inc. — Form D/A
Neuralieve, Inc. of SUNNYVALE, CA, a company, filed a Form D amendment with the SEC on 2010-12-10. The offering totals $15.5M, of which $7.5M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2010-12-10
- Form: D/A
- Accession: 0001506998-10-000002
- Industry: Other Health Care
- Exemptions: 06
- Total offering: $15.5M
- Amount sold: $7.5M
- Remaining: $8.0M
- Investors: 25
- Date of first sale: 2009-12-30
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-137660
Issuer
- Name: Neuralieve, Inc.
- CIK: 0001477913
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 240 N. WOLFE ROAD, SUNNYVALE, CA, 94085
- Phone: 408-245-6400
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Annette Campbell-White | Director | Framingham, MA |
| David Fischell | Director | Eatontown, NJ |
| Robert Fischell | Director | Rutherford, NJ |
| Frank Fisher | Director | Sunnyvale, CA |
| Mark Lortz | Director | Sunnyvale, CA |
| Terese Baker | Executive Officer | San Jose, CA |
| Robert Fischell | Executive Officer | Rutherford, NJ |
| Ting Lu | Executive Officer | Sunnyvale, CA |
| Carol Schembri | Executive Officer | Sunnyvale, CA |
Other filings by this issuer (1)
More